Cargando…

Oxidized Low-Density Lipoprotein Serum Concentrations and Cardiovascular Morbidity in End Stage of Renal Disease †

Introduction: Oxidized low-density lipoprotein (ox-LDL) is considered a main biomarker of oxidative stress, a common characteristic in end stage renal disease. We examined the relationship between ox-LDL serum concentrations and cardiovascular disease in permanent hemodiafiltration therapy patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Raikou, Vaia, Kardalinos, Vasilios, Kyriaki, Despina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162541/ https://www.ncbi.nlm.nih.gov/pubmed/29933629 http://dx.doi.org/10.3390/jcdd5030035

Ejemplares similares

Glucose Serum Concentrations and Cardiovascular Disease in Patients on the End Stage of Renal Disease without Diabetes Mellitus
por: Raikou, Vaia D., et al.
Publicado: (2015)

Association between Low Serum Bicarbonate Concentrations and Cardiovascular Disease in Patients in the End-Stage of Renal Disease
por: Raikou, Vaia D., et al.
Publicado: (2016)

The Association between Intradialytic Hypertension and Metabolic Disorders in End Stage Renal Disease
por: Raikou, Vaia D., et al.
Publicado: (2018)

Triglycerides to High-Density Lipoprotein Cholesterol Ratio Predicts Chronic Renal Disease in Patients without Diabetes Mellitus (STELLA Study)
por: Raikou, Vaia D., et al.
Publicado: (2020)

Importance of serum phosphate in elderly patients with diabetes mellitus
por: Raikou, Vaia D, et al.
Publicado: (2020)

The relationship between glycemic control, beta2-microglobulin and inflammation in patients on maintenance dialysis treatment
por: Raikou, Vaia D, et al.
Publicado: (2015)

Serum phosphate and chronic kidney and cardiovascular disease: Phosphorus potential implications in general population
por: Raikou, Vaia D
Publicado: (2021)

Metabolic Syndrome and Chronic Renal Disease
por: Raikou, Vaia D., et al.
Publicado: (2018)

Effects of smoking cessation using varenicline on the serum concentrations of oxidized high-density lipoprotein: Comparison with high-density lipoprotein cholesterol
por: Umeda, Akira, et al.
Publicado: (2022)

Mortality and Low Serum Bicarbonate Level in Patients on Hemodiafiltration versus Peritoneal Dialysis
por: Raikou, V. D., et al.
Publicado: (2018)

PON1 concentration and high-density lipoprotein characteristics as cardiovascular biomarkers
por: González, Fátima E. Murillo, et al.
Publicado: (2019)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
por: Krolewski, Andrzej S., et al.
Publicado: (2012)

High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease
por: Kosmas, Constantine E, et al.
Publicado: (2018)

High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport
por: Anderson, Josephine L.C., et al.
Publicado: (2017)

Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
por: Ma, Kun Ling, et al.
Publicado: (2018)

Serum concentrations of small dense low‐density lipoprotein cholesterol and lipoprotein(a) are related to coronary arteriostenosis in Takayasu arteritis
por: Chen, Si, et al.
Publicado: (2021)

Relation between high density lipoprotein particles concentration and cardiovascular events: a meta-analysis
por: Wu, YuJing, et al.
Publicado: (2018)

Serum Low Density Lipoprotein Cholesterol Concentration Is Not Dependent on Cholesterol Synthesis and Absorption in Healthy Humans
por: Stellaard, Frans, et al.
Publicado: (2022)

High-Density Lipoproteins in Non-Cardiovascular Diseases
por: Zanotti, Ilaria
Publicado: (2022)

Establishing a threshold to predict risk of cardiovascular disease from the serum triglyceride and high-density lipoprotein concentrations in persons with spinal cord injury
por: La Fountaine, Michael F., et al.
Publicado: (2018)

The Urine Urokinase Concentration in End Stage Renal Disease with Acquired Renal Cyst
por: Hong, Sae Yong, et al.
Publicado: (1991)

The Decrease in Serum Total Cholesterol and Low-Density Lipoprotein (LDL) Concentrations With the Initiation of Hemodialysis Despite a Concomitant Increase in Serum Albumin Concentrations
por: Sam, Ramin, et al.
Publicado: (2023)

Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
por: Tian, Li, et al.
Publicado: (2010)

Tamoxifen, serum lipoproteins and cardiovascular risk.
por: Bruning, P. F., et al.
Publicado: (1988)

Association of trajectories of non-high-density lipoprotein cholesterol concentration with risk of cardiovascular disease: the Kailuan Study
por: Ding, Xiong, et al.
Publicado: (2023)

Low Serum High Density Lipoprotein Cholesterol Concentration is an Independent Predictor for Enhanced Inflammation and Endothelial Activation
por: Wan Ahmad, Wan Nor Hanis, et al.
Publicado: (2015)

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
por: Briel, Matthias, et al.
Publicado: (2009)

Effect of Vitamin Supplementation on Serum Oxidized Low-Density Lipoprotein Levels in Male Subjects with Cardiovascular Disease Risk Factors
por: Najafpour Boushehri, Saeid, et al.
Publicado: (2012)

Bone mineral density and mortality in end-stage renal disease patients
por: Iseri, Ken, et al.
Publicado: (2020)

Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis
por: Aoki, Jiro, et al.
Publicado: (2017)

Cardiovascular risk in children and adolescents with end stage renal disease
por: do Val, Maria Luiza, et al.
Publicado: (2019)

Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease
por: Moradi, Hamid, et al.
Publicado: (2019)

Effect of Periodic Transfusion on Erythropoietin Concentration in End Stage Renal Disease
por: Hong, Sae Yong, et al.
Publicado: (1992)

High density lipoproteins-based therapies for cardiovascular disease
por: Gao, Xuan, et al.
Publicado: (2010)

Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
por: Kornmueller, Karin, et al.
Publicado: (2019)

Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease
por: Furuhashi, Masato, et al.
Publicado: (2011)

Serum Lipid, Lipoprotein and Oxidatively Modified Low Density Lipoprotein Levels in Active or Inactive Patients with Behçet's Disease
por: Cimen, Fuat, et al.
Publicado: (2012)

Mineral and bone disorders, morbidity and mortality in end-stage renal failure patients on chronic dialysis
por: MOLDOVAN, DIANA, et al.
Publicado: (2016)

High-Density Lipoproteins and Serum Amyloid A (SAA)
por: Webb, Nancy R.
Publicado: (2021)

Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease
por: Gao, Shen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r5p5fbimc3nb4l4db1ivdsmdp4